GFAP

Accuracy of the novel automated VIDAS TBI (GFAP, UCH-L1) assay for ruling out acute intracranial traumatic lesions in patients under 65 years of age with mild traumatic brain injury in an Emergency Department: an exploratory study

Study Overview In the realm of acute traumatic brain injury (TBI), efficiently and accurately identifying patients at risk for intracranial […]

Accuracy of the novel automated VIDAS TBI (GFAP, UCH-L1) assay for ruling out acute intracranial traumatic lesions in patients under 65 years of age with mild traumatic brain injury in an Emergency Department: an exploratory study Read Post »

Whole-blood point-of-care glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 biomarkers after traumatic brain injury in the US: a prospective diagnostic prediction of intracranial injury on head CT

Study Overview The investigation centers on the utility of two specific biomarkers—glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase

Whole-blood point-of-care glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 biomarkers after traumatic brain injury in the US: a prospective diagnostic prediction of intracranial injury on head CT Read Post »

Scroll to Top